1492PBPI-9016M, a novel c-Met inhibitor, in pretreated advanced solid tumor: Results from a first-in-human, phase I, dose-escalation study. (23rd October 2018) - Hu, X; Zheng, X; Mo, H; Cui, X; Ding, L; Tan, F; Hu, P; Shi, Y